Rutgers scholar Fredric Wondisford is available to discuss how dexamethasone can be used to treat critically ill COVID-19 patients following a study in the United Kingdom that found the steroid drug reduced the number of deaths.
“The preliminary results from this non-peer-reviewed study are not surprising given the overwhelming inflammation found in COVID-19 patients and the potency of dexamethasone, which is a cortisol used in treating autoimmune conditions like rheumatoid arthritis and certain blood cancers like leukemia,” said Wondisford, professor of medicine at the Rutgers Robert Wood Johnson School of Medicine. “What is unknown and potentially problematic from a public health perspective is whether dexamethasone would be helpful in all stages of the COVID-19 infection because it can also compromise the body’s ability to fight a viral infection.”
“The public should be advised that dexamethasone has a powerful and generalized suppressive effect on the body’s immune system and has been only shown to help COVID 19 patients on a ventilator or oxygen potentially."
Rutgers University–New Brunswick has broadcast-quality TV and radio studios available for remote live or taped interviews. For more information, contact Neal Buccino email@example.com
Rutgers Biomedical and Health Sciences (RBHS) takes an integrated approach to educating students, providing clinical care and conducting research, all with the goal of improving human health. Aligned with Rutgers University–New Brunswick, and collaborating university-wide, RBHS includes eight schools, a behavioral health network and four centers and institutes. RBHS offers an outstanding education in medicine, dentistry, pharmacy, public health, nursing, biomedical research and the full spectrum of allied health careers. RBHS clinical and academic facilities are located throughout the state.